Idera Pharmaceuticals Inc HXXB-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 7:55 PM CET
3.58quote price arrow up+0.16 (+4.68%)
52 week range
0.84 - 4.92

...

Loading . . .

KEY STATS

  • Open3.46
  • Day High3.60
  • Day Low3.46
  • Prev Close3.42
  • 52 Week High4.92
  • 52 Week High Date01/21/21
  • 52 Week Low0.84
  • 52 Week Low Date03/13/20
  • Market Cap
  • Shares Out
  • 10 Day Average Volume1,023.45
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change150.35

RATIOS/PROFITABILITY

  • EPS (TTM)-2.43
  • P/E (TTM)-1.47
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Idera Pharmaceuticals Inc News

There is no recent news for this security.

Latest HXXB-FF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Idera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapeutics for oncology and rare diseases. The Company utilizes two drug discovery technology platforms to design and develop drug candidates, which include Toll-like receptor (TLR) targeting technology and third-generation antisense (3GA) technology. Using TLR technology, the Company designs synthetic oligonucleotide-based drug candidates...
james Geraghty J.D.
Chairman
Vincent Milano CPA
President
Daniel Soland
Chief Operating Officer
John Kirby CPA
Chief Financial Officer
Address
505 Eagleview Blvd Ste 212
Exton, PA
19341-1199
United States